Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

NCT05681195 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Primary Central Nervous System Lymphoma
Secondary Central Nervous System Lymphoma
Relapsed Cancer
Refractory Cancer

Interventions

DRUG: Pemetrexed
DRUG: Zanubrutinib
PROCEDURE: Autologous Stem Cell Transplant (ASCT)
RADIATION: Whole Brain Radiation Therapy (WBRT)

Sponsor

Baptist Health South Florida

Collaborators

[object Object]